Gurbakhash Kaur, MD, discusses the potential role of CELMoDs in the multiple myeloma treatment paradigm.
Gurbakhash Kaur, MD
Advertisement
Gurbakhash Kaur, MD, is an assistant professor of medicine, hematology and medical oncology at Mount Sinai.
Articles by Gurbakhash Kaur, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves SimpleScreen CRC Blood-Based Screening Test for Average-Risk Adults
2
Sonesitatug Vedotin Improves Overall Survival in Second- and Later-Line CLDN18.2-Positive Gastric/GEJ Cancer
3
Volume, Biomarkers, and Cost Realities Guide ARPI Sequencing in Advanced Prostate Cancer
4
Updated Safusidenib Data Show Durable Responses in Grade 2 IDH1-Mutant Glioma
5